About this trial
1. Assess frequency of hepatic steatosis among patients in patients with Ischemic stroke without previous risk factors 2. Assess outcomes morbidity and mortality ischemic stroke in correlation with hepatic steatosis .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Newly diagnosed ischemic cerebral stroke exceeding of window phase without obvious risk factors.
patients above 18 years.
patients below 60 years.
Disqualifiers
patients have obvious risk factors including: smoking, DM , Hypertension ,renal patients , cardiovascular diseases (AF , valvular disease ,reduced systolic function ,chronic HCV ,HBV).
patients below 18 years.
patients above 60 years.
patients refused to contribute to this study.
Trial population
Newly diagnosed ischemic cerebral stroke patients exceeding of window phase without obvious risk factors.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Assess frequency of hepatic steatosis among patients in patients with Ischemic stroke without previous risk factors
Secondary outcomes
Assess outcomes morbidity and mortality ischemic stroke in correlation with hepatic steatosis .
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: